絞り込み

16533

広告

1077件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety.

Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays.

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis.

Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-Analysis.

All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism.

Approaches to Direct Oral Anticoagulant Selection in Practice.

Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.

Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation.

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE) - Trial Design.

Betrixaban: A Novel Factor Xa Inhibitor for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients.

Delayed hypersensitivity to new oral anticoagulants. Demonstration of cross reactivity for the drug category and definition of non-irritant concentrations for patch tests.

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.

Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016-2017.

Outcome of direct oral anticoagulant treatment for acute lower limb deep venous thrombosis after total knee arthroplasty or total hip arthroplasty.

Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs).

Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48.

[Oral Anticoagulants: Management of Elective and Emergency Surgery].

Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK.

Dabigatran-induced nephropathy and its successful treatment with Idarucizumab - case report and literature review.

Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta-analysis of prospective studies.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります